Menu
GWAS Study

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.

Aulchenko YS, Ripatti S, Lindqvist I et al.

19060911 PubMed ID
GWAS Study Type
22562 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AY
Aulchenko YS
RS
Ripatti S
LI
Lindqvist I
BD
Boomsma D
HI
Heid IM
PP
Pramstaller PP
PB
Penninx BW
JA
Janssens AC
WJ
Wilson JF
ST
Spector T
MN
Martin NG
PN
Pedersen NL
KK
Kyvik KO
KJ
Kaprio J
HA
Hofman A
FN
Freimer NB
JM
Jarvelin MR
GU
Gyllensten U
CH
Campbell H
RI
Rudan I
JA
Johansson A
MF
Marroni F
HC
Hayward C
VV
Vitart V
JI
Jonasson I
PC
Pattaro C
WA
Wright A
HN
Hastie N
PI
Pichler I
HA
Hicks AA
FM
Falchi M
WG
Willemsen G
HJ
Hottenga JJ
DG
de Geus EJ
MG
Montgomery GW
WJ
Whitfield J
MP
Magnusson P
SJ
Saharinen J
PM
Perola M
SK
Silander K
IA
Isaacs A
SE
Sijbrands EJ
UA
Uitterlinden AG
WJ
Witteman JC
OB
Oostra BA
EP
Elliott P
RA
Ruokonen A
SC
Sabatti C
GC
Gieger C
MT
Meitinger T
KF
Kronenberg F
DA
Döring A
WH
Wichmann HE
SJ
Smit JH
MM
McCarthy MI
VD
van Duijn CM
PL
Peltonen L
Chapter II

Abstract

Summary of the research findings

Recent genome-wide association (GWA) studies of lipids have been conducted in samples ascertained for other phenotypes, particularly diabetes. Here we report the first GWA analysis of loci affecting total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides sampled randomly from 16 population-based cohorts and genotyped using mainly the Illumina HumanHap300-Duo platform. Our study included a total of 17,797-22,562 persons, aged 18-104 years and from geographic regions spanning from the Nordic countries to Southern Europe. We established 22 loci associated with serum lipid levels at a genome-wide significance level (P < 5 x 10(-8)), including 16 loci that were identified by previous GWA studies. The six newly identified loci in our cohort samples are ABCG5 (TC, P = 1.5 x 10(-11); LDL, P = 2.6 x 10(-10)), TMEM57 (TC, P = 5.4 x 10(-10)), CTCF-PRMT8 region (HDL, P = 8.3 x 10(-16)), DNAH11 (LDL, P = 6.1 x 10(-9)), FADS3-FADS2 (TC, P = 1.5 x 10(-10); LDL, P = 4.4 x 10(-13)) and MADD-FOLH1 region (HDL, P = 6 x 10(-11)). For three loci, effect sizes differed significantly by sex. Genetic risk scores based on lipid loci explain up to 4.8% of variation in lipids and were also associated with increased intima media thickness (P = 0.001) and coronary heart disease incidence (P = 0.04). The genetic risk score improves the screening of high-risk groups of dyslipidemia over classical risk factors.

21,848 European ancestry individuals, 714 Orcadian individuals

Chapter III

Study Statistics

Key metrics and study information

22562
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Finland, Sweden, Australia, Italy, Netherlands, Germany, U.K., Croatia, Norway, Denmark
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.